What You Need to Know About Monoclonal Canine (Dog) Antibody

What You Need to Know About Monoclonal Canine (Dog) Antibody
Dogs are the first domesticated animals that have been widely kept as working,
hunting, and pet companions. According to recent coarse estimates, there are currently
between 700 million and one billion dogs, making them the most abundant predators
in the world. We human beings regard dogs as our best friends. Thus, to protect dogs,
our friends, from diseases should be listed among the catalogue of biopharmaceutical
research.
Antibody phage display, especially monoclonal antibody phage display, is commonly
used in disease prevention and treatment. However, when it comes to monoclonal
canine antibody, not much information could be offered. Creative Biolabs, fortunately,
is an exceptional.
As a recognized leader in the fields of phage display and antibody engineering,
Creative Biolabs is specialized in phage display antibody library technology to make
monoclonal rabbit, chicken, llama, dog, monkey, mouse and human antibodies.
Particularly, they are proud to be the first and the only company to provide
monoclonal canine antibody generation services.
Based on their extensive experiences in phage display library construction and
screening, scientists in Creative Biolabs have created several immunized canine
antibody libraries, from which they have successfully isolated a number of high
affinity antibodies using panning techniques. Through this strategy, they can generate
custom monoclonal canine antibodies that have the potential to be used in a wide
range of biomedical applications, including the treatment of malignant, infectious,
inflammatory and autoimmune diseases in dogs, which pave the way for exploration
of such applications in canine medicine.
As for antigens that are not suitable for immunization, Creative Biolabs are also
pleased to make a custom synthetic canine antibody library for you based on our full
understanding of the canine antibody repertoires. They can take the major framework
sequence of light chain heavy chain of canine antibody repertoires and then create
mutations or variations in all 6 CDR regions (or 2 CDR3 regions). Combined with
various mutation strategies, thay can produce canine antibodies against any antigens,
including those that are toxic and of no immune response in animals.
Apart from developing monoclonal canine antibodies, Creative Biolabs also
established a platform for monoclonal antibody caninization, murinization and
humanization services.
Learn more Monoclonal Canine (Dog) Antibody Production from Creative Biolabs.
About Creative Biolabs

Creative Biolabs Creative Biolabs is specialized in providing custom biotechnology
and pharmaceutical services that cover the full scope of biotechnology needs of early
drug discovery and drug development. As a trusted provider of the most cost-effective
outsourcing solutions, Creative Biolabs has been working for a large number of
satisfied clients from biotechnology and pharmaceutical companies as well as
government and academic research laboratories all over the world.